Skip to Content

Vendors


Mick Farrell

Vendors

ResMed signals possible end to CPAP crunch

January 27, 2023Liz Beaulieu, Editor

SAN DIEGO – ResMed was able to take its AirSense 10 fully connected CPAP device off allocation in the U.S. market in January, CEO Mick Farrell said during a conference call to discuss its financial results for the second quarter fiscal year 2023.  Furthermore, the company expects to be able to meet all demand before the end of this calendar year, he said, paving the way for providers to get patients on therapy in days or weeks vs. months at the height of a supply crisis created by a...

CPAP, Mick Farrell, ResMed


Read Full Articlered right arrow icon

Vendors

ResMed reports ‘strong sales growth’ 

January 26, 2023HME News Staff

SAN DIEGO – ResMed reported revenue increased by 16% to $1.03 billion in the second quarter of fiscal year 2023 compared to the same period the previous year.  Net income was $224.9 million vs. $216.2 million.  “During the second quarter, we significantly increased production and delivery of flow generator devices to meet the incredible demand from customers, resulting in strong sales growth in the Americas, and solid overall performance for our business across 140 countries,”...

CPAP Therapy, ResMed


Read Full Articlered right arrow icon

Vendors

Popularity of EVs squeezes access to compound used in concentrators 

January 25, 2023HME News Staff

BOULDER, Colo. – As the demand for electric vehicles has grown, the price of lithium, which, when combined with zeolite, allows oxygen concentrators to generate oxygen at purity levels of 90% or higher, is experiencing significant increases, according to a bulletin from Quality Biomedical.  Lithium is a key component of the batteries used in EVs and certain sieve beds of oxygen concentrators.  “As the demand for EVs has increased, the price of lithium is experiencing significant...

Oxygen Concentrators, Quality Biomedical


Read Full Articlered right arrow icon

Lewis Gradon

Vendors

F&P: Mask sales have remained strong

January 23, 2023HME News Staff

AUCKLAND, New Zealand – Fisher & Paykel Healthcare expects full year operating revenue for the 2023 financial year to be within the range of about $1.55 billion to $1.6 billion, the company announced on Jan. 19.  In F&P’s Homecare Product Group, sales of obstructive sleep apnea masks have remained strong, said Lewis Gradon, managing director and CEO.  “Our mask sales growth rate is currently tracking above that of our first half as global supply of CPAP hardware...

CPAP, Fisher & Paykel Healthcare


Read Full Articlered right arrow icon

Vendors

Masimo, Royal Philips expand RPM partnership

January 19, 2023HME News Staff

IRVINE, Calif. and ANDOVER, Mass. – Masimo and Royal Philips have announced an expansion of their partnership to augment remote patient monitoring capabilities in home telehealth applications with the Masimo W1 advanced health tracking watch.   “Expanding our partnership with Philips in this way is a win-win for patients and clinicians everywhere and is an important part of our multi-year plan to bring the best of hospital monitoring to the home, while continuing to improve access...

Masimo, Royal Philips, Telehealth


Read Full Articlered right arrow icon

Vendors

Belluscura makes 'considerable progress’ 

January 16, 2023HME News Staff

LONDON and PLANO, Texas – Belluscura shipped or received orders for 2,850 X-PLOR portable oxygen concentrators by Dec. 31, 2022, the company stated in a trading update for the year.  The company anticipates its adjusted EBITDA loss will be in line with market expectations. Its retained cash balances of $1.8 million amounted to $11.9 million, with inventory and inventory deposits.  "During the year we have made considerable progress,” said CEO Robert Rauker. “We have...

Belluscura, Portable Oxygen Concentrator


Read Full Articlered right arrow icon

OxyGo sees sleep market as ‘great opportunity’

Vendors

OxyGo sees sleep market as ‘great opportunity’

January 13, 2023Liz Beaulieu, Editor

ORLANDO, Fla. – OxyGo first started selling CPAP devices in 2021, when providers were struggling with inventory due to a major recall and supply chain challenges, then officially launched OxyGo SLEEP in late 2022.   The company, which already sells portable oxygen concentrators, used its network to tap into a vendor overseas for CPAP devices that had been cleared by the U.S. Food and Drug Administration under Emergency Use Authorization.  “When we found it, we thought,...

OxyGo, OxyGo SLEEP, Sleep Apnea


Read Full Articlered right arrow icon

Vendors

Inogen meets expectations in Q4 

January 10, 2023HME News Staff

GOLETA, Calif. – Inogen estimates preliminary, unaudited total revenue of $87.5 million to $88.5 million for the fourth quarter of 2022, representing year-over-year growth of 14.5% to 15.8%.  It estimates total revenue of $376.7 million to $377.7 million for the full year, representing year-over-year growth of 5.2% to 5.5%.  “Despite the prevailing macroeconomic pressures and headwinds resulting from our efforts to continue upgrading the operating disciplines in our DTC...

Home oxygen therapy, Inogen, respiratory care


Read Full Articlered right arrow icon

Earl Lawson

Vendors

CAIRE expands into diagnostics

January 6, 2023Liz Beaulieu, Editor

BALL GROUND, Ga. – CAIRE on Jan. 4 finalized its acquisition of MGC Diagnostics Holdings, positioning itself to cover another step in the “patient journey,” said Earl Lawson, president and CEO.  MGC is a manufacturer of non-invasive cardiorespiratory diagnostic systems like pulmonary function testing systems and spirometers.  “It really improves the way we’re supporting the patient,” Lawson said. “We were looking for an opportunity that was...

Caire, MGC Holdings


Read Full Articlered right arrow icon

Vendors

Belluscura takes ‘big step’ internationally 

December 29, 2022HME News Staff

LONDON and PLANO, Texas – Belluscura has entered into its first international distribution agreement outside of the United States with MedHealth Supplies of South Africa. MedHealth has placed orders for 2022 and 2023, with deliveries starting immediately. “This is a big step in Belluscura’s expansion outside of the U.S.,” said Robert Rauker, CEO of Belluscura. MedHealth’s founders have a long history in the supplemental oxygen space, and we are excited to work...

Belluscura, Portable Oxygen Concentrator, X-PLOR


Read Full Articlered right arrow icon